Fact CheckerSign in

NCT07598240Active, not recruiting

Is a Standard Hand Rehabilitation Program Sufficient in Rheumatoid Arthritis Patients With Central Sensitization

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

The presence of central sensitization leads to overestimation of pain sensitivity and disease activity in rheumatoid arthritis (RA) patients. Central sensitization should not be overlooked in RA patients to avoid over-treatment for inflammation and to determine the need for treatment of nociplastic pain. While literature contains no studies comparing alternative programs with the standard hand rehabilitation program in the presence of central sensitization in rheumatoid arthritis patients, the objective of this study is to investigate whether desensitization exercises provide additional benefit in this patient group.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
81 (actual)
First submitted
12 May 2026
Start date
22 Aug 2025
Primary completion date
22 Dec 2025
Lead sponsor
Fulya Coşkun
NCT number
NCT07598240

What you commit to

  • Study type: Interventional
  • Participants enrolled: 81
  • From 22 Aug 2025 to the primary completion date, 22 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having had surgery on the extremity to be treated within the last 6 months

Other

  • Patients with active arthritis
  • Patients with cognitive deficit
  • Patients who do not consent to participate in the study

Criteria the registry did not label

  • Inclusion \*Rheumatoid Arthritis Group Without Central Sensitization (Group 1):
  • Being between 18-75 years of age
  • Not having had upper extremity surgery within the last 1 year
  • Patients without active arthritis
  • No change in medical treatment in the last 3 months
  • Having mild-moderate disease activity according to DAS28
    • \*Rheumatoid Arthritis Group with Central Sensitization (Group 2):
  • Being between 18-75 years of age
  • Not having had upper extremity surgery within the last 1 year
  • Patients without active arthritis
  • No change in medical treatment in the last 3 months
  • Having mild-moderate disease activity according to DAS28
    • \*Rheumatoid Arthritis Group with Central Sensitization (Group 3):
  • Being between 18-75 years of age
  • Not having had upper extremity surgery within the last 1 year
  • Patients without active arthritis
  • No change in medical treatment in the last 3 months
  • Having mild-moderate disease activity according to DAS28
    • Criteria:
    • \-

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Haydarpaşa Numune Eğitim Ve Araştirma Hastanesi Validebağ Ek Hizmet Binasi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.